What to Know About the New Nasal Spray for Tough Depression
6 days ago · The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
5 days ago · The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment …
Major depression: FDA approves esketamine nasal spray
6 days ago · The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least …
FDA approves 'ketamine' nasal spray for depression - Live Science
2 days ago · TRD is a severe type of major depressive disorder in which patients' symptoms are not relieved by ... the new FDA approval means that patients will be able use the ketamine …
FDA Approves Spravato Nasal Spray for Major Depressive Disorder
Jan 23, 2025 · The U.S. Food and Drug Administration (FDA) this week approved Johnson & Johnson’s Spravato (a ketamine-derived) nasal spray to treat major depressive disorder …
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA Approves Spravato Nasal Spray for Treatment-Resistant
Jan 23, 2025 · The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate …
FDA approves Johnson & Johnson's nasal spray for depression as ...
Jan 21, 2025 · The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, …
Esketamine Nasal Spray in Major Depressive Disorder: A Meta
Jan 10, 2025 · Esketamine nasal spray in conjunction with an antidepressant effectively controls short-term and long-term depressive symptoms in major depressive disorder and treatment …
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...